#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Von Willebrand's disease Kidney transplant rejection Methylmalonic acidaemia Autoinflammation with infantile enterocolitis Retinopathy of prematurity Hyperoxaluria Bone marrow disorder Palmoplantar pustulosis Short-bowel syndrome Plasma cell myeloma recurrent Follicular lymphoma Primary amyloidosis Hypoparathyroidism Infantile spasms Neutropenia More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Aicardi-Goutieres syndrome – Diagnostics Mastocytosis Leukoencephalopathy – Trials in Disease Testicular leiomyosarcoma – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Life with Disease Krabbe’s disease – Basic Information Short-bowel syndrome – Life with Disease Leiomyosarcoma – Diagnostics Mucopolysaccharidosis II – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mirabegron Bi 1291583 Cobicistat Mifamurtide IBANDRONIC ACID Melphalan Camizestrant Irinotecan Hydrochloride VORMATRIGINE Rp1 SEPOFARSEN LUTETIUM LU-177 Taurine HYDROGEN PEROXIDE Warfarin Treg02 Erythromycin Lactobionate Cabotegravir Apocynin Lovotibeglogene Autotemcel More therapies…

    Learn about Your Condition

    Psychotic disorder Cutibacterium acnes infection Plasma cell leukaemia Pelvic venous thrombosis Gastrointestinal carcinoma Mixed dementia Cushing's syndrome Pancreatic failure Hernia repair Red blood cell abnormality Fatty acid oxidation disorder Polyneuropathy Pancreaticoduodenectomy Normal pressure hydrocephalus Notalgia paraesthetica More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing ABP 692 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    Belgium Bulgaria Croatia Czechia Denmark France +9

  • Study of Tisagenlecleucel for Treating Adult Patients with Resistant or Relapsed B-cell Acute Lymphoblastic Leukemia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • B precursor type acute leukaemia
    Investigated Drugs:
    • Tisagenlecleucel
    Poland

  • Study on the Effectiveness and Safety of Metformin and Methyl Aminolevulinate in Daylight Therapy for Actinic Keratosis Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Actinic keratosis
    Investigated Drugs:
    • Metformin Embonate
    • Methyl Aminolevulinate Hydrochloride
    Spain

  • Study on Electrochemotherapy with Bleomycin for Patients with Colorectal Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Bleomycin
    Denmark

  • Study on Improving Small Bowel Visualization in Capsule Endoscopy for Patients Using Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, and Simeticone

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Macrogol 3350
    • Sodium Ascorbate
    • Simeticone
    Spain

  • Study on Pembrolizumab as Maintenance Therapy for Patients with Unresectable Stage III Non-Small Cell Lung Cancer After Chemo-Radiotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Pembrolizumab
    Italy
Previous Page
1 … 805 806 807 808 809 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!